The WHO estimates that 422 million people worldwide suffer from diabetes, with the majority residing in low- or middle-income ...

Contrary to some celebrities who avoid disclosing whether they used medication to help them lose weight, Jim Gaffigan ...

Weight loss drugs like tirzepatide and semaglutide are growing in popularity and offer significant health benefits, but they ...

Dr. Oz has talked about the perks of probiotics — live microorganisms sometimes known as “good bacteria” — including ...

Oz's first confirmation hearing as nominee for CMS head is Friday. Back in 2016, Oz was named in a class action lawsuit ...

Tirzepatide and semaglutide were associated with larger QALY gains (incremental gains of 0.35 and 0.25 over lifestyle ...

Tirzepatide — a drug that acts both as a GLP-1 agonist and a GIP agonist — is the active ingredient in an even more powerful ...

A new study found that fair prices for medications like Wegovy and Zepbound would be hundreds less per month than they are ...

A study finds that significant weight loss increases the risk for individuals with cardiovascular disease. New research has ...

After years of weight loss drug shortages, the FDA is saying there’s now an adequate supply for most medications and they ...

Compounding pharmacies will have to stop producing copycats of tirzepatide, the active ingredient in the blockbuster weight ...

GLP-1 therapy is a groundbreaking approach in the treatment of obesity and metabolic health issues. GLP-1, or glucagon-like ...